Transcriptome analysis comparing gene expression in control samples, lesional and non-lesional skin of psoriasis patients and a clear down-regulation of S100A8 and S100A9 expression during response to IL-17 directed therapy also points to a relevant role of pro-inflammatory S100-alarmins in the course of psoriasis. This evidence concerns the gene IL17A and psoriasis.